Revival Gold Completes Acquisition of Ensign Minerals and Announces Release of Escrowed Funds and Conversion of Subscription Receipts
May 30, 2024 13:57 ET
|
Revival Gold Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival...
Harness Therapeutics appoints Leading World Experts in Neurodegenerative Diseases to its Scientific Advisory Board (SAB)
May 30, 2024 07:00 ET
|
Harness Therapeutics
Newly established SAB of prominent geneticists, biologists and Huntington’s disease specialists’ marks pivotal step in accelerating progress of lead programme HRN001 Cambridge, UK, May 30, 2024:...
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
May 28, 2024 07:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United Kingdom, May 28, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization...
deepull appoints Didier Deltort to its Board of Directors
May 22, 2024 03:00 ET
|
DeepUll
deepull appoints Didier Deltort to its Board of Directors Barcelona, Spain – 22 May 2024 – deepull, a medical diagnostics company developing culture-free diagnostic solutions for rapid pathogen...
Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives
May 16, 2024 14:00 ET
|
Tevogen Bio Inc
Former police chief & FBI National Academy graduate, William Keane, to work with functional leads, ensure policies, procure Tevogen’s lab space.
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R&D Committee
May 14, 2024 03:00 ET
|
Nouscom Srl
Dr. Gallagher, current President of R&D at Syndax Pharmaceuticals and former Chief Medical Officer and Head of Development at AbbVie, brings significant experience of end-to-end development that...
Bitfarms Announces Acceleration of Previously Announced Termination of CEO and Provides Update on New CEO Appointment
May 13, 2024 07:00 ET
|
Bitfarms Ltd.
- Geoffrey Morphy terminated as CEO and Nicolas Bonta appointed on interim basis -- CEO Executive search nearing completion - This news release constitutes a “designated news release” for...
Arcadis' shareholders appoint board members and approve dividend
May 08, 2024 11:05 ET
|
Arcadis N.V.
Arcadis 2024 Annual General MeetingArcadis' shareholders appoint board members and approve dividend Virginie Duperat-Vergne reappointed as Chief Financial Officer (CFO) for an additional four-year...
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
April 30, 2024 07:00 ET
|
ViaNautis Bio
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors
April 30, 2024 02:00 ET
|
ViaNautis Bio
ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors Co-Founder of Spark Therapeutics with over 20 years of industry experience to support ViaNautis Bio in its next...